DigiPath today announces PathTrade, the exchange initiative that provides affordable and innovative digital pathology solutions, while also providing means for underserved communities to access pathology educational and medical experts throughout the world. <\/p>\n
Henderson, Nevada (PRWEB) October 04, 2012 <\/p>\n
PathTrade provides existing telepathology users an affordable means to upgrade discontinued telepathology systems with a DigiPath solution. DigiPath will provide $500 to $5,000 as trade-in credit for upgrading to PathScope and\/or PathLive value. Additionally, DigiPath will refurbish system, and deploy system without any additional fees, in communities in need of pathology educational and medical experts. DigiPath has identified many underserved communities in Africa, India, Mideast, Southeast Asia, Caribbean, and South America, for installations in 2012. <\/p>\n
DigiPath has been asked numerous times to assist in providing systems in countries of need of pathology expertise, said Steve Barbee, Vice President of DigiPath, Inc., Vice President of DigiPath, Inc. DigiPath is delighted to not only assist our clients in upgrading systems, but in bringing advanced pathology practices to underserved communities worldwide. <\/p>\n
Please email info(at)digipath(dot)biz if interested in upgrading your telepathology system for world health benefits. <\/p>\n
About DigiPath, Inc. <\/p>\n
DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital pathology solutions. DigiPaths advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 750 installations at community pathology practices, hospitals, academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide. DigiPath has offices within Kansas, California, Maryland, and Nevada. Please see http:\/\/digipath.biz<\/a> for more details. <\/p>\n SAFE HARBOR STATEMENT <\/p>\n This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. DigiPath has tried, whenever possible, to identify these forward-looking statements using words such as \"anticipates,\" \"believes,\" \"estimates,\" \"expects,\" \"plans,\" \"intends,\" \"potential\" and similar expressions. These statements reflect DigiPath's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause DigiPath's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. DigiPath undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements. <\/p>\n DigiPath Media Relations DigiPath, inc. (702) 527-2060 Email Information <\/p>\n<\/p>\n Excerpt from: DigiPath today announces PathTrade, the exchange initiative that provides affordable and innovative digital pathology solutions, while also providing means for underserved communities to access pathology educational and medical experts throughout the world. Henderson, Nevada (PRWEB) October 04, 2012 PathTrade provides existing telepathology users an affordable means to upgrade discontinued telepathology systems with a DigiPath solution. DigiPath will provide $500 to $5,000 as trade-in credit for upgrading to PathScope and\/or PathLive value. Continue reading
\nDigiPath Provides Affordable Upgrade & Pathology Access to Areas in Need<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"